Literature DB >> 4985431

Chikungunya virus vaccine prepared by Tween-ether extraction.

K H Eckels, V R Harrison, F M Hetrick.   

Abstract

Chikungunya virus vaccines prepared by Tween 80 and ether inactivation of virus grown in green monkey kidney cell cultures were shown to be as immunogenic as comparable Formalin-inactivated vaccines. Both types of vaccine stimulated hemagglutination-inhibiting, complement-fixing, and neutralizing antibody and afforded protection to mice against a live virus challenge. It was shown after Tween-ether treatment of chikungunya virus that the infectivity of the virus was lost and the hemagglutinin titer was increased. By characterization of the resultant hemagglutinin by sucrose and cesium chloride density gradient centrifugation, it was found that the extracted particle was smaller in size and greater in density than the parent virus particle. Removal of lipid may account for the alterations in the physical characteristics of the infectious virus particle. Conditions for treatment of chikungunya virus with Tween and ether were found that preserved high titers of hemagglutinin as well as the immunogenicity of the virus preparations.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4985431      PMCID: PMC376676          DOI: 10.1128/am.19.2.321-325.1970

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  11 in total

1.  STUDIES ON THE STRUCTURE OF A HEMAGGLUTINATING COMPONENT OF A GROUP A ARBO VIRUS (SINDBIS).

Authors:  M MUSSGAY
Journal:  Virology       Date:  1964-08       Impact factor: 3.616

2.  THE EPIDEMIC OF ACUTE HAEMORRHAGIC FEVER, CALCUTTA, 1963: EPIDEMIOLOGICAL INQUIRY.

Authors:  S P RAMAKRISHNAN; H M GELFAND; P N BOSE; P N SEHGAL; R N MUKHERJEE
Journal:  Indian J Med Res       Date:  1964-07       Impact factor: 2.375

3.  COMPARISONS OF SEROLOGIC AND FEBRILE RESPONSES IN HUMANS TO VACCINATION WITH INFLUENZA A VIRUSES OR THEIR HEMAGGLUTININS.

Authors:  F M DAVENPORT; A V HENNESSY; F M BRANDON; R G WEBSTER; C D BARRETT; G O LEASE
Journal:  J Lab Clin Med       Date:  1964-01

4.  STUDIES ON MEASLES VIRUS HEMAGGLUTINATION.

Authors:  S FUNAHASHI; T KITAWAKI
Journal:  Biken J       Date:  1963-07

5.  An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. II. General description and epidemiology.

Authors:  W H LUMSDEN
Journal:  Trans R Soc Trop Med Hyg       Date:  1955-01       Impact factor: 2.184

6.  A simple plaque-inhibition test for the study of arthropod-borne viruses.

Authors:  J S PORTERFIELD
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

7.  Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.

Authors:  D H CLARKE; J CASALS
Journal:  Am J Trop Med Hyg       Date:  1958-09       Impact factor: 2.345

8.  Comparative immunogenicities of chikungunya vaccines prepared in avian and mammalian tissues.

Authors:  V R Harrison; L N Binn; R Randall
Journal:  Am J Trop Med Hyg       Date:  1967-11       Impact factor: 2.345

9.  The use of tween-80-ether for preparation of haemagglutinins of arboviruses.

Authors:  A Saturno
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

10.  Measles vaccination. V. The booster effect of purified hemagglutinin in children previously immunized with this product or formalin-killed vaccine.

Authors:  E Norrby; R Lagercrantz; S Gard
Journal:  Acta Paediatr Scand       Date:  1966-01
View more
  21 in total

1.  Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus.

Authors:  Adam D DeZure; Nina M Berkowitz; Barney S Graham; Julie E Ledgerwood
Journal:  J Infect Dis       Date:  2016-12-15       Impact factor: 5.226

2.  Inactivated eastern equine encephalomyelitis vaccines prepared in monolayer and concentrated suspension chick embryo cultures.

Authors:  A White; S Berman; J P Lowenthal
Journal:  Appl Microbiol       Date:  1971-11

3.  Comparative immunogenicities of Chikungunya vaccines propagated in monkey kidney monolayers and chick embryo suspension cultures.

Authors:  A White; S Berman; J P Lowenthal
Journal:  Appl Microbiol       Date:  1972-05

Review 4.  Vaccine and Therapeutic Options To Control Chikungunya Virus.

Authors:  Ann M Powers
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

Review 5.  Biology and pathogenesis of chikungunya virus.

Authors:  Olivier Schwartz; Matthew L Albert
Journal:  Nat Rev Microbiol       Date:  2010-07       Impact factor: 60.633

6.  A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis.

Authors:  Danher Wang; Andreas Suhrbier; Adam Penn-Nicholson; Jan Woraratanadharm; Joy Gardner; Min Luo; Thuy T Le; Itaru Anraku; Michael Sakalian; David Einfeld; John Y Dong
Journal:  Vaccine       Date:  2011-02-12       Impact factor: 3.641

7.  A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection.

Authors:  Wataru Akahata; Zhi-Yong Yang; Hanne Andersen; Siyang Sun; Heather A Holdaway; Wing-Pui Kong; Mark G Lewis; Stephen Higgs; Michael G Rossmann; Srinivas Rao; Gary J Nabel
Journal:  Nat Med       Date:  2010-01-28       Impact factor: 53.440

Review 8.  Chikungunya virus and prospects for a vaccine.

Authors:  Scott C Weaver; Jorge E Osorio; Jill A Livengood; Rubing Chen; Dan T Stinchcomb
Journal:  Expert Rev Vaccines       Date:  2012-09       Impact factor: 5.217

9.  Immunogenicity of purified, inactivated chikungunya virus in monkeys.

Authors:  E Nakao; S Hotta
Journal:  Bull World Health Organ       Date:  1973-05       Impact factor: 9.408

10.  Zoonotic infections in military scout and tracker dogs in Vietnam.

Authors:  A D Alexander; L N Binn; B Elisberg; P Husted; D L Huxsoll; J D Marshall; C F Needy; A D White
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.